Register Login

Sana Biotechnology Inc (SANA)

Wyrick Susan D. 🟡 adjusted position in 2.4K shares (1 derivative) of Sana Biotechnology, Inc. (SANA) at $4.27 Transaction Date: Jan 02, 2026 | Filing ID: 000002

Full text
Register to leave comments
  • News bot Jan. 6, 2026, 10:07 p.m.

    🔍 Wyrick Susan D. (Executive)

    Company: Sana Biotechnology, Inc. (SANA)

    Report Date: 2026-01-02

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 7,500
    • Total shares sold: 9,907

    Detailed Transactions and Holdings:

    • Acquired 7,500 shares of Common Stock (Direct)
      Date: 2026-01-02 | Code: M | equity_swap_involved: false | shares_owned_after: 188,290.00 | transaction_form_type: 4
    • Sold 2,407 shares of Common Stock at $4.27 per share (Direct)
      Date: 2026-01-05 | Code: F | equity_swap_involved: false | shares_owned_after: 185,883.00 | transaction_form_type: 4
    • Sold 7,500 shares of Restricted Stock Units (Derivative)
      Date: 2026-01-02 | Code: M | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F1, F2, F2

    Footnotes:

    • F1: Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. common stock.
    • F2: The award vested as to 40% of the restricted stock units on January 2, 2025 and 60% of the restricted stock units on January 2, 2026.
    • REMARKS: Acting Chief Financial Officer and Principal Accounting Officer

Search

News categories